Cathay Biotech Inc.
688065
Rank in Stocks
#4171
Cathay Biotech Inc. specializes in biochemical products, producing and... Cathay Biotech Inc. specializes in biochemical products, producing and marketing bio-based polyamide, bio-based DN5, long chain dibasic acids, and biobutanol. The company's corporate base is located in Shanghai, China.
Share Price
$5.37
Last synced: 2026-10-20
Market Cap
$3.87B
Change (1 day)
0.95%
Change (1 year)
-20.14%
Country
CN
Trade Cathay Biotech Inc. (688065)
Category
Basic Materials
Revenue for Cathay Biotech Inc. (688065)
Revenue in Jun 2026 TTM: $510.80M
According to Cathay Biotech Inc. latest financial reports the company's current revenue (TTM) is $510.80M. In 2023 the company made a revenue of $298.67M a decrease compared to the revenue in the year 2022 that was $353.89M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cathay Biotech Inc. from 2016 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $510.80M | 26.05% |
| 2024 | $405.24M | 35.68% |
| 2023 | $298.67M | -15.60% |
| 2022 | $353.89M | -4.83% |
| 2021 | $371.86M | 62.25% |
| 2020 | $229.18M | -16.72% |
| 2019 | $275.19M | 7.73% |
| 2018 | $255.45M | 21.96% |
| 2017 | $209.45M | 56.51% |
| 2016 | $133.82M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $8.93B | 1,648.53% |
TW
|
|
| $16.35B | 3,101.64% |
JP
|
|
| - | - |
DE
|
|
| $25.95B | 4,980.63% |
SA
|
|
| $33.57B | 6,471.86% |
CN
|
